2014
- What evidence supports the efficacy of dalbavancin for the treatment of ABSSSIs?
- What treatment options are available for the reversal of novel oral anticoagulants?
- What is the evidence for the safety and efficacy of tedizolid for the treatment of ABSSSIs?
- What is the status of biosimilars in the United States?
- Preexposure prophylaxis for HIV prevention: What are the new guidelines?
- How should acute pain be managed in patients taking Suboxone?
- What is the new evidence behind the effectiveness of β-blocker therapy for outcomes post-myocardial infarction?
- What are the findings of the HEAT-PPCI trial?
- What is the role of thrombolysis in submassive pulmonary embolism?
- What evidence supports the use of extended or continuous infusions for carbapenem administration?
- What evidence describes the effect of inhaled morphine for dyspnea or pain?
- What is the new guidance regarding palivizumab (Synagis®) administration for respiratory syncytial virus?
- What are the proposals of the new USP <800> chapter, ' Hazardous Drugs – Handling in Healthcare Settings ? '
- How should beyond-use-dates for compounded preparations be determined?
- Is intravenous ketamine useful for the treatment of major depressive disorder?
- Can patients with recurrent C difficile infection be treated with a prepared fecal microbiota transplant product?
- What data are available comparing liposomal bupivacaine to other agents?
- What is the Target: Stroke initiative and its effect on stroke outcomes?
- What are the recommendations regarding blood pressure management in patients with an acute ischemic stroke?
- What evidence supports the efficacy of the new oral factor Xa inhibitor, edoxaban?
- Does testosterone increase the risk of a cardiovascular event?
- What is the effective dose and duration of oral ribavirin for immunocompromised adult patients with RSV infection?
- Is there any information regarding reducing the adverse effects from acetylcysteine in acetaminophen overdose?
- What are the current guidelines on treatment of hyponatremia with vasopressin antagonists?
- Is there a benefit to using colloid solutions versus crystalloid solutions as fluid resuscitation for patients with hypovolemic shock?
- What drug products may be used in patients with anemia or hemorrhage who are Jehovah’s Witnesses?
- What data are available to direct the dosing weight used for daptomycin in obesity?
- Are there benefits to using genotype-guided warfarin dosing for INR control?
- Does perioperative use of selective serotonin reuptake inhibitors increase the risk of adverse outcomes?
- What is the evidence for the use of albumin for treatment of intradialytic hypotension?
- What are the key features of the new hypertension treatment guidelines?
- How do the novel oral anticoagulants compare to low-molecular-weight heparin for prevention of venous thromboembolism in patients undergoing total hip or knee replacements?
- Is there evidence to support the use of lidocaine to reduce pain associated with potassium infusions?
- What is the latest evidence associating statin use with myopathy?
- What are current best practices for prevention of central-line associated bloodstream infections?
- What are the key features of the new cholesterol treatment guidelines?